Advanced Innovative Medicine Revenue and Competitors
Estimated Revenue & Valuation
- Advanced Innovative Medicine's estimated annual revenue is currently $620k per year.
- Advanced Innovative Medicine's estimated revenue per employee is $155,000
Employee Data
- Advanced Innovative Medicine has 4 Employees.
- Advanced Innovative Medicine grew their employee count by 0% last year.
Advanced Innovative Medicine's People
Name | Title | Email/Phone |
---|
Advanced Innovative Medicine Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Advanced Innovative Medicine?
Advanced Innovative Medicine, LLC (AIM), is focused on developing innovative medical therapies using adult stem cells for end-stage heart disease and severe peripheral vascular diseases. AIM has developed a proprietary technology that allows us to use adult stem cells for regrowth and repair of damaged cells or tissue. We have a state-of-the-art, FDA registered laboratory in Orlando, Florida. The product is made in an FDA and cGMP regulated clean room. There we process the blood to produce the stem cell product, and do research on other stem cell therapies. AIM’s Adult Stem Cell Therapy has been successfully used across the globe in many treatment facilities with leading team of scientists and experts.
keywords:N/AN/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 4 | N/A | N/A |
#2 | $0.3M | 4 | 0% | N/A |
#3 | $0.3M | 4 | -71% | N/A |
#4 | $0.4M | 4 | 0% | N/A |
#5 | $0.4M | 4 | 0% | N/A |